Mercury Drug Corporation Sustainability Profile
Mercury Drug Corporation, a leading name in the Philippine pharmaceutical industry, has been a cornerstone of healthcare since its establishment in 1945. Headquartered in Quezon City, PH, the company operates extensively across the archipelago, providing essential health products and services to millions of Filipinos. Specialising in retail pharmacy, Mercury Drug offers a wide range of prescription medications, over-the-counter drugs, and health-related products. Its commitment to quality and customer service has solidified its reputation as a trusted provider in the market. Notable achievements include being the first pharmacy chain in the Philippines to introduce a loyalty programme, enhancing customer engagement and satisfaction. With a strong market position, Mercury Drug continues to innovate and adapt, ensuring that it meets the evolving needs of its customers while maintaining its legacy of excellence in the healthcare sector.
DitchCarbon Score
How does Mercury Drug Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mercury Drug Corporation's score of 17 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mercury Drug Corporation's reported carbon emissions
Mercury Drug Corporation, headquartered in the Philippines, currently does not have specific carbon emissions data available for recent years. As a current subsidiary, it does not inherit emissions data from a parent company, and there are no documented reduction targets or climate pledges outlined in the available information. Despite the absence of quantifiable emissions data, Mercury Drug Corporation's commitment to addressing climate change can be inferred through its participation in various sustainability initiatives. However, without specific targets or achievements reported, the company's climate commitments remain vague. As the company continues to navigate its environmental responsibilities, it is essential for stakeholders to monitor any future disclosures regarding emissions and sustainability efforts.
How Carbon Intensive is Mercury Drug Corporation's Industry?
How Carbon Intensive is Mercury Drug Corporation's Location?
Mercury Drug Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Mercury Drug Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
